NASDAQ:LQDA Liquidia Technologies (LQDA) Stock Price, News & Analysis $22.43 +0.53 (+2.42%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$22.56 +0.14 (+0.60%) As of 08:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Liquidia Technologies Stock (NASDAQ:LQDA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Liquidia Technologies alerts:Sign Up Key Stats Today's Range$21.91▼$22.6250-Day Range$17.68▼$29.2252-Week Range$9.71▼$29.94Volume1.67 million shsAverage Volume2.86 million shsMarket Capitalization$1.93 billionP/E RatioN/ADividend YieldN/APrice Target$32.38Consensus RatingModerate Buy Company Overview Liquidia Technologies, Inc. is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery. The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH). LIQ861 aims to offer a more convenient and potentially more consistent dosing approach compared with current liquid-based nebulized therapies. Besides PAH, Liquidia is exploring additional indications and dosage forms to expand the use of its PRINT platform, including collaborations focused on vaccine adjuvants and other respiratory applications. Liquidia Technologies was founded to translate advanced particle-engineering science into therapeutic benefit and has assembled a team with experience in respiratory drug development, regulatory affairs and clinical operations. The company conducts clinical research primarily in the United States, and it plans to pursue regulatory filings in major markets following the completion of pivotal studies. Under the leadership of President and CEO Chris Critelli, Liquidia continues to advance its pipeline toward potential commercialization.AI Generated. May Contain Errors. Read More Liquidia Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreLQDA MarketRank™: Liquidia Technologies scored higher than 61% of companies evaluated by MarketBeat, and ranked 407th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingLiquidia Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, no hold ratings, and 2 sell ratings.Upside PotentialLiquidia Technologies has a consensus price target of $32.38, representing about 44.3% upside from its current price of $22.43.Amount of Analyst CoverageLiquidia Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Liquidia Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Liquidia Technologies are expected to grow in the coming year, from ($1.51) to ($1.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia Technologies is -13.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia Technologies is -13.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia Technologies has a P/B Ratio of 24.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Liquidia Technologies' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted21.45% of the outstanding shares of Liquidia Technologies have been sold short.Short Interest Ratio / Days to CoverLiquidia Technologies has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in Liquidia Technologies has recently increased by 7.89%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLiquidia Technologies does not currently pay a dividend.Dividend GrowthLiquidia Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted21.45% of the outstanding shares of Liquidia Technologies have been sold short.Short Interest Ratio / Days to CoverLiquidia Technologies has a short interest ratio ("days to cover") of 6.9.Change versus previous monthShort interest in Liquidia Technologies has recently increased by 7.89%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Liquidia Technologies this week, compared to 6 articles on an average week.Search Interest20 people have searched for LQDA on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.MarketBeat Follows5 people have added Liquidia Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Liquidia Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,689,864.00 in company stock.Percentage Held by Insiders30.10% of the stock of Liquidia Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.54% of the stock of Liquidia Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Liquidia Technologies' insider trading history. Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LQDA Stock News HeadlinesLiquidia Technologies (NASDAQ:LQDA) Director Raman Singh Sells 45,524 SharesSeptember 18, 2025 | insidertrades.comLiquidia Technologies (NASDAQ:LQDA) Director Sells $220,650.00 in StockSeptember 6, 2025 | insidertrades.comGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.October 6 at 2:00 AM | Stansberry Research (Ad)BTIG biotech analyst holds an analyst/industry conference callOctober 4 at 2:37 AM | msn.comLiquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual MeetingSeptember 29, 2025 | finance.yahoo.comIs it a Wise Move to Buy Liquidia Corp. (LQDA) Shares?September 23, 2025 | insidermonkey.comLiquidia Corporation (LQDA): A Bull Case Theory September 16, 2025 | insidermonkey.comLiquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) SymposiumSeptember 11, 2025 | markets.businessinsider.comSee More Headlines LQDA Stock Analysis - Frequently Asked Questions How have LQDA shares performed this year? Liquidia Technologies' stock was trading at $11.76 at the beginning of 2025. Since then, LQDA shares have increased by 90.7% and is now trading at $22.43. How were Liquidia Technologies' earnings last quarter? Liquidia Technologies, Inc. (NASDAQ:LQDA) announced its earnings results on Tuesday, August, 12th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.06. The business's revenue was up 141.5% compared to the same quarter last year. Read the conference call transcript. When did Liquidia Technologies IPO? Liquidia Technologies (LQDA) raised $50 million in an initial public offering on Thursday, July 26th 2018. The company issued 4,500,000 shares at $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. Who are Liquidia Technologies' major shareholders? Top institutional shareholders of Liquidia Technologies include GAMMA Investing LLC. Insiders that own company stock include Caligan Partners Lp, Roger Jeffs, Russell Schundler, Paul B Manning, Michael Kaseta, Rajeev Saggar, Scott Moomaw, Robert A Lippe, Dana Boyle, Jason Adair, Sarah Krepp and Raman Singh. View institutional ownership trends. How do I buy shares of Liquidia Technologies? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Liquidia Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia Technologies investors own include JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Ford Motor (F), Predictive Oncology (POAI), Tesla (TSLA), Advanced Micro Devices (AMD) and Abbott Laboratories (ABT). Company Calendar Last Earnings8/12/2025Today10/06/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMedical Equipment Current SymbolNASDAQ:LQDA CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees50Year Founded2004Price Target and Rating Average Price Target for Liquidia Technologies$32.38 High Price Target$43.00 Low Price Target$13.00 Potential Upside/Downside+44.3%Consensus RatingModerate Buy Rating Score (0-4)2.70 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($1.70) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$130.39 million Net Margins-732.17% Pretax Margin-784.54% Return on Equity-232.96% Return on Assets-60.81% Debt Debt-to-Equity Ratio9.84 Current Ratio2.49 Quick Ratio2.41 Sales & Book Value Annual Sales$14 million Price / Sales137.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.91 per share Price / Book24.65Miscellaneous Outstanding Shares86,090,000Free Float60,178,000Market Cap$1.93 billion OptionableOptionable Beta0.15 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:LQDA) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.